Trial · NCT03976323
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Induction Phase | STARTED | Pembrolizumab + Pemetrexed + Platinum Therapy (Induction Phase) | 1,003 | |
| Induction Phase | STARTED | Pembrolizumab + Olaparib (Maintenance Phase) | 0 | |
| Induction Phase | STARTED | Pembrolizumab + Pemetrexed (Maintenance Phase) | 0 | |
| Induction Phase | COMPLETED | Pembrolizumab + Pemetrexed + Platinum Therapy (Induction Phase) | 672 | |
| Induction Phase | COMPLETED | Pembrolizumab + Olaparib (Maintenance Phase) | 0 | |
| Induction Phase | COMPLETED | Pembrolizumab + Pemetrexed (Maintenance Phase) | 0 | |
| Induction Phase | NOT COMPLETED | Pembrolizumab + Pemetrexed + Platinum Therapy (Induction Phase) | 331 | |
| Induction Phase | NOT COMPLETED | Pembrolizumab + Olaparib (Maintenance Phase) | 0 | |
| Induction Phase | NOT COMPLETED | Pembrolizumab + Pemetrexed (Maintenance Phase) | 0 | |
| Maintenance Phase | STARTED | Pembrolizumab + Pemetrexed + Platinum Therapy (Induction Phase) | 0 | |
| Maintenance Phase | STARTED | Pembrolizumab + Olaparib (Maintenance Phase) | 337 | |
| Maintenance Phase | STARTED | Pembrolizumab + Pemetrexed (Maintenance Phase) | 335 | |
| Maintenance Phase | Treated | Pembrolizumab + Pemetrexed + Platinum Therapy (Induction Phase) | 0 | |
| Maintenance Phase | Treated | Pembrolizumab + Olaparib (Maintenance Phase) | 337 | |
| Maintenance Phase | Treated | Pembrolizumab + Pemetrexed (Maintenance Phase) | 332 | |
| Maintenance Phase | Received Second Course of Pembrolizumab | Pembrolizumab + Pemetrexed + Platinum Therapy (Induction Phase) | 0 | |
| Maintenance Phase | Received Second Course of Pembrolizumab | Pembrolizumab + Olaparib (Maintenance Phase) | 7 | |
| Maintenance Phase | Received Second Course of Pembrolizumab | Pembrolizumab + Pemetrexed (Maintenance Phase) | 13 | |
| Maintenance Phase | COMPLETED | Pembrolizumab + Pemetrexed + Platinum Therapy (Induction Phase) | 0 | |
| Maintenance Phase | COMPLETED | Pembrolizumab + Olaparib (Maintenance Phase) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03976323/flow